Stay updated on Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This appears to be an internal versioning change and does not modify the study details or user-visible content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe update shows a revision from v3.4.1 to v3.4.2 with no substantive changes to the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1; no study data, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a Show glossary option and updated administrative labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page adds a Locations section with Jiangsu listed as a site and updates the Jiangsu location entry; the HHS Vulnerability Disclosure link is removed and the revision note updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.